Bee venom phospholipase A2 prevents prion peptide induced-cell death in neuronal cells

International Journal of Molecular Medicine

Volumn 28, Issue 5, 2011, Pages 867-873

  Jeong, Jae Kyo ^a   Moon, Myung Hee ^a   Bae, Bum Chul ^a   Lee, You Jin ^a   Seol, Jae Won ^a   Park, Sang Youel ^a  

^a Chonbuk National University   (South Korea)

Author keywords

Bee venom phospholipase A2; Prion disease; Prion protein (106 126); Secretory phospholipase A2

Indexed keywords

BEE VENOM; BEE VENOM PHOSPHOLIPASE A2; CASPASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOLIPASE A2; PRION PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; HUMAN; HUMAN CELL; NERVE CELL; NEUROTOXICITY; PRIORITY JOURNAL;

BEE VENOMS; BLOTTING, WESTERN; CELL DEATH; CELL LINE, TUMOR; HUMANS; L-LACTATE DEHYDROGENASE; NEURONS; PEPTIDE FRAGMENTS; PHOSPHOLIPASES A2; PRIONS;

EID: 80053101148     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.730     Document Type: Article

References (37)

1. Brandner S, Klein MA, Frigg R, et al: Neuroinvasion of prions: insights from mouse models. Exp Physiol 85: 705-712, 2000.
2. Kretzschmar HA: Molecular pathogenesis of prion diseases. Eur Arch Psychiatry Clin Neurosci 249 (Suppl 3): S56-S63, 1999.
3. Avrahami D and Gabizon R: Age-related alterations affect the susceptibility of mice to prion infection. Neurobiol Aging (In press).
4. Diez M, Groth D, DeArmond SJ, Prusiner SB and Hokfelt T: Changes in neuropeptide expression in mice infected with prions. Neurobiol Aging 28: 748-765, 2007. (Pubitemid 46349345)
5. Jeong JK, Moon MH, Seol JW, Seo JS, Lee YJ and Park SY: Prion peptide-mediated cellular prion protein overexpression and neuronal cell death can be blocked by aspirin treatment. Int J Mol Med 27: 689-693, 2011.
6. Mallucci G, Dickinson A, Linehan J, Klohn PC, Brandner S and Collinge J: Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302: 871-874, 2003. (Pubitemid 37339628)
7. Radford HE and Mallucci GR: The role of GPI-anchored PrP C in mediating the neurotoxic effect of scrapie prions in neurons. Curr Issues Mol Biol 12: 119-127, 2010.
8. Sim VL and Caughey B: Ultrastructures and strain comparison of under-glycosylated scrapie prion fibrils. Neurobiol Aging 30: 2031-2042, 2009.
9. Didonna A and Legname G: Aberrant ERK 1/2 complex activation and localization in scrapie-infected GT1-1 cells. Mol Neurodegener 5: 29, 2010.
10. Freixes M, Rodriguez A, Dalfo E and Ferrer I: Oxidation, glycoxidation, lipoxidation, nitration, and responses to oxidative stress in the cerebral cortex in Creutzfeldt-Jakob disease. Neurobiol Aging 27: 1807-1815, 2006. (Pubitemid 44572578)
11. Seo JS, Seol JW, Moon MH, Jeong JK, Lee YJ and Park SY: Hypoxia protects neuronal cells from human prion protein fragment-induced apoptosis. J Neurochem 112: 715-722, 2010.
12. Jeong JK, Seol JW, Moon MH, et al: Cellular cholesterol enrichment prevents prion peptide-induced neuron cell damages. Biochem Biophys Res Commun 401: 516-520, 2010.
13. Seo JS, Moon MH, Jeong JK, et al: SIRT1, a histone deacetylase, regulates prion protein-induced neuronal cell death. Neurobiol Aging: Nov 11, 2010 (Epub ahead of print).
14. Gu Y, Fujioka H, Mishra RS, Li R and Singh N: Prion peptide 106-126 modulates the aggregation of cellular prion protein and induces the synthesis of potentially neurotoxic transmembrane PrP. J Biol Chem 277: 2275-2286, 2002. (Pubitemid 34968815)
15. Forloni G, Angeretti N, Chiesa R, et al: Neurotoxicity of a prion protein fragment. Nature 362: 543-546, 1993. (Pubitemid 23113029)
16. Singh N, Gu Y, Bose S, Kalepu S, Mishra RS and Verghese S: Prion peptide 106-126 as a model for prion replication and neurotoxicity. Front Biosci 7: a60-a71, 2002.
17. Mingarro I, Perez-Paya E, Pinilla C, Appel JR, Houghten RA and Blondelle SE: Activation of bee venom phospholipase A2 through a peptide-enzyme complex. FEBS Lett 372: 131-134, 1995.
18. Rodriguez De Turco EB, Jackson FR, DeCoster MA, Kolko M and Bazan NG: Glutamate signalling and secretory phospholipase A2 modulate the release of arachidonic acid from neuronal membranes. J Neurosci Res 68: 558-567, 2002. (Pubitemid 34575621)
19. Masuda S, Yamamoto K, Hirabayashi T, et al: Human group III secreted phospholipase A2 promotes neuronal outgrowth and survival. Biochem J 409: 429-438, 2008. (Pubitemid 351184961)
20. Kudo I and Murakami M: Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat 68-69: 3-58, 2002.
21. Scott DL, Otwinowski Z, Gelb MH and Sigler PB: Crystal structure of bee-venom phospholipase A2 in a complex with a transition-state analogue. Science 250: 1563-1566, 1990. (Pubitemid 120034367)
22. Burke JE and Dennis EA: Phospholipase A2 structure/function, mechanism, and signaling. J Lipid Res 50 (Suppl): S237-S242, 2009.
23. Sun GY, Shelat PB, Jensen MB, He Y, Sun AY and Simonyi A: Phospholipases A2 and inflammatory responses in the central nervous system. Neuromolecular Med 12: 133-148, 2010.
24. Sato H, Kato R, Isogai Y, et al: Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis. J Biol Chem 283: 33483-33497, 2008.
25. Sato H, Taketomi Y, Isogai Y, et al: Group III secreted phospholipase A2 regulates epididymal sperm maturation and fertility in mice. J Clin Invest 120: 1400-1414, 2010.
26. Valentin E, Ghomashchi F, Gelb MH, Lazdunski M and Lambeau G: Novel human secreted phospholipase A(2) with homology to the group III bee venom enzyme. J Biol Chem 275: 7492-7496, 2000. (Pubitemid 30159644)
27. Yang X, Sheng W, He Y, et al: Secretory phospholipase A2 type III enhances alpha-secretase-dependent amyloid precursor protein processing through alterations in membrane fluidity. J Lipid Res 51: 957-966, 2010.
28. Melo JB, Agostinho P and Oliveira CR: Prion protein aggregation and neurotoxicity in cortical neurons. Ann NY Acad Sci 1096: 220-229, 2007. (Pubitemid 47092515)
29. Corsaro A, Thellung S, Villa V, et al: Prion protein fragment 106-126 induces a p38 MAP kinase-dependent apoptosis in SH-SY5Y neuroblastoma cells independently from the amyloid fibril formation. Ann NY Acad Sci 1010: 610-622, 2003. (Pubitemid 38265055)
30. O'Donovan CN, Tobin D and Cotter TG: Prion protein fragment PrP-(106-126) induces apoptosis via mitochondrial disruption in human neuronal SH-SY5Y cells. J Biol Chem 276: 43516-43523, 2001.
31. Sakudo A and Ikuta K: Prion protein functions and dysfunction in prion diseases. Curr Med Chem 16: 380-389, 2009.
32. Schneider B, Mutel V, Pietri M, Ermonval M, Mouillet-Richard S and Kellermann O: NADPH oxidase and extracellular regulated kinases 1/2 are targets of prion protein signaling in neuronal and nonneuronal cells. Proc Natl Acad Sci USA 100: 13326-13331, 2003. (Pubitemid 37444741)
33. Pietri M, Caprini A, Mouillet-Richard S, et al: Overstimulation of PrPC signaling pathways by prion peptide 106-126 causes oxidative injury of bioaminergic neuronal cells. J Biol Chem 281: 28470-28479, 2006. (Pubitemid 44414560)
34. Bate C, Salmona M, Diomede L and Williams A: Squalestatin cures prion-infected neurons and protects against prion neurotoxicity. J Biol Chem 279: 14983-14990, 2004. (Pubitemid 38618891)
35. Bate C, Tayebi M, Diomede L, Salmona M and Williams A: Glimepiride reduces the expression of PrPc, prevents PrPSc formation and protects against prion mediated neurotoxicity in cell lines. PLoS One 4: e8221, 2009.
36. Lee WR, Kim SJ, Park JH, et al: Bee venom reduces atherosclerotic lesion formation via anti-inflammatory mechanism. Am J Chin Med 38: 1077-1092, 2010.
37. Yang EJ, Jiang JH, Lee SM, et al: Bee venom attenuates neuro-inflammatory events and extends survival in amyotrophic lateral sclerosis models. J Neuroinflammation 7: 69, 2010.